These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 12794828

  • 1. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
    Szalai AJ, Weaver CT, McCrory MA, van Ginkel FW, Reiman RM, Kearney JF, Marion TN, Volanakis JE.
    Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 3. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein.
    Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW.
    Arthritis Rheum; 2005 Feb; 52(2):642-50. PubMed ID: 15692982
    [Abstract] [Full Text] [Related]

  • 4. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L, Winkler TH, Kalberer CP, Jourdan M, Melchers F, Rolink AG.
    J Exp Med; 1996 Sep 01; 184(3):853-61. PubMed ID: 9064345
    [Abstract] [Full Text] [Related]

  • 5. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 01; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 6. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB.
    Arthritis Rheum; 2009 Jun 01; 60(6):1775-84. PubMed ID: 19479860
    [Abstract] [Full Text] [Related]

  • 7. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.
    Yoshida H, Satoh M, Behney KM, Lee CG, Richards HB, Shaheen VM, Yang JQ, Singh RR, Reeves WH.
    Arthritis Rheum; 2002 Aug 01; 46(8):2235-44. PubMed ID: 12209530
    [Abstract] [Full Text] [Related]

  • 8. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr 01; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

  • 9. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
    Zykova SN, Seredkina N, Benjaminsen J, Rekvig OP.
    Arthritis Rheum; 2008 Mar 01; 58(3):813-25. PubMed ID: 18311834
    [Abstract] [Full Text] [Related]

  • 10. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U, Letz M, Schneider A, Amann K, Winkler TH.
    Int Immunol; 2001 Dec 01; 13(12):1461-9. PubMed ID: 11717187
    [Abstract] [Full Text] [Related]

  • 11. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP.
    Arthritis Rheum; 2006 Mar 01; 54(3):914-26. PubMed ID: 16508974
    [Abstract] [Full Text] [Related]

  • 12. Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice.
    Gatto M, Ghirardello A, Luisetto R, Bassi N, Fedrigo M, Valente M, Valentino S, Del Prete D, Punzi L, Doria A.
    J Autoimmun; 2016 Nov 01; 74():208-216. PubMed ID: 27405845
    [Abstract] [Full Text] [Related]

  • 13. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P, LaStant J, Keirstead N, Whittard T, Ayala J, Stefanova S, Garrido R, Dimaano N, Hilton H, Giron M, Lau KY, Hang J, Postelnek J, Kim Y, Min S, Patel A, Woods J, Ramanujam M, DeMartino J, Narula S, Xu D.
    Arthritis Rheum; 2013 Sep 01; 65(9):2380-91. PubMed ID: 23754328
    [Abstract] [Full Text] [Related]

  • 14. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.
    Gioud M, Kotzin BL, Rubin RL, Joslin FG, Tan EM.
    J Immunol; 1983 Jul 01; 131(1):269-74. PubMed ID: 6863918
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
    Carlsten H, Holmdahl R, Tarkowski A.
    Immunology; 1991 Jun 01; 73(2):186-90. PubMed ID: 2071164
    [Abstract] [Full Text] [Related]

  • 16. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.
    Hirose S, Sekigawa I, Ozaki S, Sato H, Shirai T.
    Clin Exp Immunol; 1984 Dec 01; 58(3):694-702. PubMed ID: 6334582
    [Abstract] [Full Text] [Related]

  • 17. Delayed onset of renal disease in mice expressing a human C-reactive protein transgene: comment on the article by Szalai et al.
    Mannik M.
    Arthritis Rheum; 2004 Feb 01; 50(2):679-80. PubMed ID: 14872520
    [No Abstract] [Full Text] [Related]

  • 18. Effects of transgenic mixed-haplotype MHC class II molecules A alpha d A beta z on autoimmune disease in New Zealand mice.
    Nishimura H, Ishikawa S, Nozawa S, Awaji M, Saito J, Abe M, Tokushima M, Kimoto M, Akakura S, Tsurui H, Hirose S, Shirai T.
    Int Immunol; 1996 Jun 01; 8(6):967-76. PubMed ID: 8671686
    [Abstract] [Full Text] [Related]

  • 19. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN, Thurman J, Izui S, Falta MT, Metzger TE, Flannery SA, Kappler J, Marrack P, Kotzin BL.
    Genes Immun; 2006 Oct 01; 7(7):555-67. PubMed ID: 16900204
    [Abstract] [Full Text] [Related]

  • 20. Lack of effect of a single injection of human C-reactive protein on murine lupus or nephrotoxic nephritis.
    Carlucci F, Cook HT, Garg A, Pepys MB, Botto M.
    Arthritis Rheum; 2010 Jan 01; 62(1):245-9. PubMed ID: 20039408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.